期刊文献+

维A酸多种方式联合阿糖胞苷或柔红霉素对体外HL-60细胞凋亡的影响 被引量:1

Different ways of combination of tretinoin with cytarabine or daunorubicin lead to variable change of HL-60's apoptosis in vitro
原文传递
导出
摘要 目的探讨维A酸(ATRA)采用多种方式与阿糖胞苷(Ara-C)或柔红霉素(DNR)联用对体外白血病细胞株HL-60凋亡的影响。方法体外培养HL-60细胞株,细胞悬液以浓度2.0×105.mL-1接种后分7组,其中A组不施加任何药物,作为空白对照;B组将Ara-C与ATRA同时联合作用48 h;C组预先用ATRA作用24 h,然后改用Ara-C继续作用24 h;D组预先用Ara-C作用24 h,然后用ATRA继续作用24 h;E组将DNR与ATRA同时联合作用48 h;F组预先用ATRA作用24 h,然后用DNR继续作用24 h;G组预先用DNR作用24 h,然后用ATRA继续作用24 h。Ara-C、DNR、ATRA给药浓度均为1.0×10-7mol.L-1。应用流式细胞仪、DNA凝胶电泳及瑞氏-吉姆萨染色观察药物以不同方式联用导致细胞凋亡变化。结果D组的HL-60细胞凋亡比例轻度增加(50±14.7)%;细胞染色体完整,瑞氏染色为明显细胞凋亡。E组和G组均导致HL-60凋亡细胞明显增多,但细胞染色体丢失明显,瑞氏染色示细胞破裂。其中E组能最大限度减少HL-60存活数量,使HL-60细胞死亡数目增加,达(4.00±0.56)%。结论同时联合使用DNR与ATRA能显著减少HL-60细胞存活率。首先应用小剂量Ara-C,随后应用ATRA可较明显增多细胞凋亡数目,并能有效控制HL-60细胞死亡方式为凋亡而非坏死。 AIM To investigate variable change of apoptosis by different ways of combination of tretinoin (ATRA) with cytarabine (Ara-C) or daunorubicin (DNR) to HL-60 cell line in vitro. METHODS HL-60 cell line was cultured in vitro, eell suspension was divided into different 7 groups: group A-G,whieh respectively were: control; Ara-C and ATRA simultaneous were applied in cells for 48 h;ATRA and Ara-C subsequently were administrated respectively for 24 h including ATRA was applied first for 24 h, then followed by Ara-C for 24 h, and in verse; DNR and ATRA simultaneously were applied for 48 h ; DNR and ATRA subsequently were administrated respectively for 24 h. Drug dose of Ara-C, DNR and ATRA was 1.0 × 10^-7 mol.L^-1. The ratio of apoptosis cells was evaluated by flow eytometry. DNA gel electrophoresis was used to determine integrity of cell' s DNA and Wright' s-Giemsa' s staining to observe morph change of cells. RESULTS The ratio of cell apoptosis in group D increased slightly, the increase range of apoptosis was (50 ± 14.7) %. Cell's DNA was kept integrity and through Wright-Giemsa' s staining, cells appeared obvious apoptosis in morph in this group. Compared with control group, two groups including group E and G caused the apoptosis ratio significantly higher. But almost all of DNA of cells in these groups' was lost and Wright' s-Giemsa' s staining results showed almost all cells swelled and broke. The alive cells' ratio in group E can be reduced in most degree and the amount of dead cells increased to degree of (4.00 ± 0.56) %. CONCLUSION DNR in combination with ATRA can significantly decrease HL-60 survival. Low dose of Ara-C is administrated first then followed by ATRA can not only increase slightly the ratio of apoptosis of HL-60 cell, but also effectively control the ways of cell death to apoptosis not necrosis.
出处 《中国临床药学杂志》 CAS 2009年第1期5-9,共5页 Chinese Journal of Clinical Pharmacy
关键词 维A酸 阿糖胞苷 柔红霉素 HL-60 联用 凋亡 tretinoin cytarabine daunorubicin HL-60 combination use apoptosis
  • 相关文献

参考文献14

  • 1Sanz MA. Treatment of acute promyelocytic leukemia[J]. Hematology Am Soc Hematol Educ Program, 2006: 147.
  • 2Ades L, Sanz M, Chevret S, et al. Treatment of newly diagnosed acute promyelocytic leukaemia: a comparison between French-Belgian-Swiss and Spanish results[J]. Blood, 2005, 106 (Suppl 1): 162a.
  • 3Lengfelder E, Saussele S, Weisser A, et al. Treatment concepts of acute promyelocytic leukemia [J]. Crit Rev Oncol Hematol, 2005, 56 (2) : 261.
  • 4Tallman MS, Andersen JW, Schiffer CA, et al. All-trans retinoic acid in acute promyelocytic leukemia[J]. N Engl J Med, 1997, 337(15): 1021.
  • 5Tallman MS, Andersen JW, Schiffer CA, et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol[J]. Blood, 2002, 100(13) : 4298.
  • 6Fenaux P, Le Deley MC, Castaigne S, et al. Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicentcr randomized study[ J ]. Blood, 1993, 82( 11 ) : 3241.
  • 7Fenaux P, Chastang C, Chevret S, et al. A randomized comparison of all-trans retinoic acid (ATRA)followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia[J]. Blocd, 1999, 94(4): 1192.
  • 8Bumett AK, Grimwade D, Solomon E, et al. Presenting white blood cell counts and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: results of the randomized MRC trial[J]. Blood, 1999, 93(12): 4131.
  • 9Aandelli F, Diviero D, Avvisati G, et al. Molecular remission in PML/ RARα-positive acute promyelecytic leukemia by combined all-trans retinoic acid and idarubicin (A]DA) therapy[J]. Blood, 1999, 90(3): 1014.
  • 10Sanz MA, Martin G, Rayon C, et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia[J]. Blood, 1999, 94(9) : 3015.

二级参考文献27

  • 1萨母布鲁克 金冬雁等(译).分子克隆实验指南(第二版)[M].北京:科学出版社,1995.348.
  • 2[1]LOTEM J, SACHS L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes[J]. Leukemia,1996,10(6):925-931.
  • 3[5]LI Y, JENKINS C W, NICHOLS M A, et al. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21[J]. Oncogene,1994,9(8):2 261-2 268.
  • 4[6]OREN M. Decision making by p53: life, death and cancer[J]. Cell Death Differ, 2003, 10(4): 431-442.
  • 5[7]PORWIT-MACDONALD A, LVORY K, WILKINSON S, et al. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia[J]. Leukemia, 1995,9(7):1 191-1 198.
  • 6Hartwell LH,Kastan MB.Cell cycle control and cancer [J].Science,1994,266:1821
  • 7Sherr CJ.Cancer cell cycle [J].Science,1996,274:1672
  • 8Hug H.Fas-mediated apoptosis in tumor formation and defense[J].BiolChem,1997,378(12):1405
  • 9DedingTao,JianhongWu,YongdongFeng,et al.New method for te analysis of cell cycle-specific apoptosis[J].Cytometry,2004,57A:70
  • 10Ben-Ezra JM,Kornstein MJ,Grimes MM,et al.Small cell carcinomas of the lung express the Bcl-2 protein [J].Am J Pathol,1994,145:1036

共引文献2

同被引文献12

  • 1郭瑛,崔玉芳.活性氧在细胞凋亡信号转导中的作用[J].感染.炎症.修复,2005,6(1):61-63. 被引量:5
  • 2Sanz M A, Lo-Coco F, Modem 呼proaches to treating acute promyelocyt-ic leukemia[j]. J Clin Oncol,2011,29(5) :495.
  • 3Fenaux P, Chomienne C, Degos L. All-trans retinoic acid andchemotherapy in the treatment of acute promyelocytic leukemia [ J].Semin Hematol, 2001,38(1) : 13.
  • 4Sieuwerts AM, Klijn JG, Peters HA, et al. The MTT tetrazolium salt as-say scrutinized: how to use this assay reliably to measure metabolie activ-ity of cell cultures in vitro for the assessment of growth characteristics,ICso-values and cell survival[j] . Eur J Clin Chem Clin Biochem, 1995,33(11):813.
  • 5季宇彬,何相晶,曲中原,等.活性氧诱导细胞凋亡的研究进展[C].第七届中药新药研究与开发信息会议论文集,2009:19.
  • 6Jiang H, Dan Z, Wang H, et al. Effect of ATRA on contents of liverretinoids,oxidative stress and hepatic injury in rat model of extrah印aticcholestasis[j]. J Huazhong Univ Sci Technolog Med Sci,2007,27(5):491.
  • 7Leibowitz B, Yu J. Mitochondrial signaling in cell death via the Bel - 2family[j] . Cancer Biol TTier,2010,9(6) :417.
  • 8G^iiotto F, Fais F, Bruno S. BH3-only proteins: the death-puppeteer’swires[j] . Cytometry A, 2010,77(1):11.
  • 9Dhanasekaran DN, Reddy EP. JNK signaling in qx>ptosis[ j]. Onco-gene, 2008,27 (48) :6245.
  • 10Xia Z,Dickens M, Raingeaud J, et al. Opposing effects of ERK andJNK-p38 MAP kinases on 平optosis[ j]. Science,1995,270(5240):1326.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部